Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Accounts Payables (2019 - 2025)

Pliant Therapeutics (PLRX) has disclosed Accounts Payables for 7 consecutive years, with $480000.0 as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 91.95% to $480000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $480000.0 through Dec 2025, down 91.95% year-over-year, with the annual reading at $480000.0 for FY2025, 91.95% down from the prior year.
  • Accounts Payables for Q4 2025 was $480000.0 at Pliant Therapeutics, down from $485000.0 in the prior quarter.
  • The five-year high for Accounts Payables was $7.3 million in Q1 2024, with the low at $480000.0 in Q4 2025.
  • Average Accounts Payables over 5 years is $3.3 million, with a median of $3.0 million recorded in 2021.
  • The sharpest move saw Accounts Payables surged 416.35% in 2024, then plummeted 92.96% in 2025.
  • Over 5 years, Accounts Payables stood at $3.0 million in 2021, then crashed by 46.82% to $1.6 million in 2022, then skyrocketed by 186.77% to $4.5 million in 2023, then soared by 31.54% to $6.0 million in 2024, then crashed by 91.95% to $480000.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $480000.0, $485000.0, and $1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.